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ABSTRACT
Background : The optimal concentration of essential oil of clove in absorption base ointment as anti-inflammatory has been studied. The development 
of formulations can be done by adding oleic acid and propylene glycol as enhancers. The purpose of this study was to determine the anti-inflammatory 
activity of the essential oil of clove in absorption base ointment formula by adding a mixture of oleic acid and propylene glycol as enhancers.
Methods: In this study, the composition of oleic acid and propylene glycol was 100% oleic acid (FI), 50% oleic acid and propylene glycol (FII), and 
100% propylene glycol (FIII). The profile of the anti-inflammatory activity essential oil of clove was carried out using male of mice Balb/C strain which 
was induced inflammatory with croton oil on back of skin. After treatment, it was sacrificed and then was taken the back of skin to get histopathological 
preparation. After that, the epidermal thickness, number of inflammatory cells, and cyclooxygenase (COX)-2 expression can be measured. 
Results : Based on the results of the test, it shows that FIII has the smallest of the amount of COX-2 expression, the number of inflammatory cells, and 
the epidermal thickness so the addition of the composition enhancer provides good anti-inflammatory activity.
Conclusion: The increasing concentration of propylene glycol caused the raising activity of essential oil of clove as anti-inflammatory. 
Keywords: Absorption base, Anti-inflammatory, Enhancer, Essential oil of clove.
INTRODUCTION
Essential oil of clove has biological activity because it contains high 
levels of eugenol [1] so can use as an antiseptic and analgesic in 
the treatment of teeth and mouth [2]. The eugenol mechanism of 
action as anti-inflammatory agent is via inhibition of prostalglandin 
synthesis and neutrophil chemotaxis. In addition, it is also able to 
inhibit the NF-kB factor in activating the tumor necrosis factor-α 
(TNF-α) and inhibiting the expression of cyclooxygenase (COX)-2 in 
lipopolysaccharide (LPS) stimulated by macrophages. Research has 
shown that eugenol suppresses TNF signals and COX-2 expression, 
which shows its potential as an anti-inflammatory agent [3-5].
Based on this activity, the study about the activity of essential oil 
of clove in formulation of cream, lotion and ointment in absorption 
base has been conducted [6-10]. The development of a formula 
for essential oil of clove was continued. One of the ways that can 
be done to develop a formula is by adding an enhancer to the 
preparation of formulation. Enhancers or penetrating enhancers 
are ingredients that can increase skin permeability or reduce skin 
impermeability. The material of the penetrating enhancers does 
not have therapeutic effect, but it can transport drugs from dosage 
forms into the skin [11].
The previous study showed that the optimal concentration essential 
oil of clove in absorption base ointment which had the best anti-
inflammatory activity and met the requirements was 2.5% [12]. This 
study was carry out to develop the formulation of essential oil of clove 
in absorption base ointment with addition of mixture of oleic acid and 
propylene glycol as enhancer to increase the capability of essential oil 
of clove as anti-inflammatory.
MATERIALS AND METHODS
Materials and tools
This study used essential oil of clove as the material which was 
obtained from the Center for Essential Oils Studies, Indonesian Islamic 
University, Sleman, Yogyakarta. The ingredients of ointment with 
pharmaceutical degree such as adeps lanae, cera alba, stearyl alcohol, 
vaseline white, oleic acid, and propylene glycol. The animal test used 
male mice of Balb/C strain with 2–3 months of age. The equipment used 
glassware (Pyrex) water bath (Memmert), analytical weighing (Ohaus), 
and microscope (Olympus).
All of the research procedures have obtained the ethical approval letter 
from the Research Ethics Committee numbered 011508062 in 2015.
Research procedure
Preparations of ointment
The essential oil of clove formulation is presented in Table 1. Each 
formula was varied a concentration of oleic and propylene glycol 
with 2.5% concentration of essential oil of clove. The preparation of 
ointment was done using fusion method. The essential oil was added 
when the base was get cold [7].
Evaluation of anti-inflammatory activity
Anti-inflammatory activity evaluation was carried out on four groups of 
Balb/C strain mice. The distribution of groups of mice was as follows:
Positive control groups
The positive control group was a group of mice that got induction of 
inflammatory agents (0.1 ml of croton oil concentration of 4%). After 
that, they were given a comparison product of 100 mg of topical sodium 
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diclofenac preparation which has been known to be efficacious as anti-
inflammatory.
Negative control group
The negative control group was a group of mice that received induction 
of inflammatory agents alone without any anti-inflammatory agents.
Healthy control group
Healthy control group was a group of mice that did not get induction of 
inflammatory agents or the treatment of samples of Formula I, II, or III. 
This group was also known as the baseline group.
Ointment of essential oil of clove without enhancer
Group of ointment without enhancers was a group of mice that got 
induction of inflammatory agents and then they were given ointment 
without enhancers.
Ointment of Formula I, II, and III
The group of Formula I, II, and III was groups of mice that received 
inflammatory agent induction; then, they were given ointment of 
Formula I, II, and III.
The inflammatory induction procedures were first cleaning the mouse 
hair in the back. After 24 h, the back of the mouse was dripped with 
0.1 ml of 4% croton oil in an area of 2×2 cm2. Then, application of 
100 mg ointment was done 30 min later. The treatment was given for 
3 days. After that, the mouse sacrificed and the back tissue was taken 
to make the painting of Haemotoxillyn eosin and COX-2 preparation. 
Microscopic parameter which was observed was epidermal thickness, 
number of inflammatory cells, and COX-2 expression from each 
treatment of group FI, FII, and FIII with the control group, healthy 
controls, positive controls, and groups of formulas without enhancers. 
The tests were carried out on five animals as the animal testing in 
each group or five replications in 3 consecutive days. Furthermore, the 
painting results were observed under a microscope using 400 times 
magnification [13].
Data analysis
Data were analyzed using simplex lattice design method to find the 
profile of epidermal thickness, the number of inflammatory cells, and 
the number of COX-2 expression. The differences between formulas 
were analyzed using one-way ANOVA with 95% level confidential.
RESULTS
Parameter to evaluate the activity of dosage form was microscopic 
observation based on epidermal thickness, the amount of inflammation 
cell, and cell number with COX-2 expression. Data were presented in 
Tables 2-4.
The results of statistical analysis showed the significant difference 
between healthy control and negative control in all parameters. It means 
that croton oil can cause irritation and swelling of the skin if it was used 
Fig. 1: The microscopic picture of epidermal thickness, 
inflammatory cells, and cells with cyclooxygenase-2 expression 
at ×400
Table 1: Formula essential oil of clove in absorption base 
ointment with addition of oleic acid and propylene glycol as 
enhancers




Adeps Lanae 2.61 2.61 2.61
Cera alba 7.11 7.11 7.11
Stearyl alcohol 2.61 2.61 2.61
White vaseline 75.17 75.17 75.17
Oleic acid 10 5 0
Propylene glycol 0 5 10
Formula I (FI) with composition of 100% oleic acid and 0% propylene glycol 
Formula II (FII) with composition of 50% oleic acid and 50% propylene glycol 
Formula III (FIII) with composition of 0% oleic acid and 100% propylene glycol
Table 2: The results of epidermal thickness test of essential oil 
of clove in absorption base ointment with the addition of oleic 
acid and propylene glycol as enhancer








*Significant difference with negative control, @significant difference with 
healthy control, +significant difference with positive control, -significant 
difference with Formula I
Table 3: The result of the number of inflammatory cell test in 
MABC absorbent base ointment with the addition of oleic acid 
enhancers and propylene glycol








*Significant difference with negative control, #significant difference with formula 
without enhancer, @significant difference with healthy control, +significant 
difference with positive control, -significant difference with Formula III 
Table 4: The results of statistical analysis of cyclooxygenase-2 
expression in MABC absorbent base ointment with the addition 
of oleic acid enhancers and propylene glycol








*Significant difference with negative control, #significant difference with 
formula without enhancer, @significant difference with healthy control, 
$significant difference with negative control, +significant difference with positive 
control, ^significant difference with Formula III
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topically [14]. On histochemical observations by using the HE method, 
crotton oil that was administrated topically can induce hyperplasia, 
infiltration of leukocytes, edema, neutrophil infiltration, a prostaglandin 
production and an increase in vascular permeability [15-17]. There was 
a significant difference between negative control and positive control. It 
means the activity of natrium diclofenac in Voltaren as active substance 
for anti-inflammatory. The mechanism of diclofenac was by inhibiting 
of the activity of COX-1 and COX-2 enzyme, thromboxane prostanoid 
receptor that influenced to release and uptake of arachidonic-acid, 
lipoxygenase enzyme, and activating of oxide-cyclic guanosine 
monophosphate pathway [18,19]. However, there was a significant 
difference between healthy control and positive. It was probably due 
to the duration of the application of Voltaren as positive control just for 
3 days so the effect was not effective yet.
The application of formula can reduce the epidermal of thickness, 
the number of inflammatory cell, and cell with COX-2 expression. It 
was supported with the result of statistical analysis that showed the 
difference significant between negative control and formula group. It 
shows the activity of eugenol as anti-inflammatory agent in essential oil 
of clove. The mechanism of eugenol as anti-inflammatory was inhibit 
the expression of COX-2 in macrophage-stimulated LPS and reduced 
production leukotrienes as mediator inflammation [20,21]. There was 
a significant difference between positive control and formula group. It 
means that the activity of eugenol was better than natrium diclofenac. 
However, there was still significant difference between healthy control 
and formula group. It was probably due to the duration of application of 
formula just for 3 days so the effect was not effective yet.
The activity of eugenol as anti-inflammatory increased with the addition 
of enhancer in the formula. The epidermal thickness, the number of 
inflammatory cells and the number of cells with COX-2 expression in 
the formula group were smaller than in the formula without enhancer. 
Enhancer could increase the capability of eugenol to penetrate the layers 
of skin so it can reach the area of inflammatory to give its activity. 
Data showed that the increasing composition of propylene glycol caused 
the decreasing of epidermal thickness, the number of inflammatory cell, 
and cell with COX-2 expression. This result similar with the previous 
study. The amount of cell with COX-2 expression, inflammatory cell and 
epidermal thickness was decline after the application of formulation 
of essential oil of clove in water soluble base ointment and lotion that 
contain mixture of oleic acid and propylene glycol as enhancer. This 
happen when the amount of propylene glycol increased [22,23]. The 
mechanism of propylene glycol as an enhancer was by dissolving the 
keratin layer of the stratum corneum, interacting, and disrupting the 
arrangement of intracellular lipids in the stratum corneum. In addition, 
propylene glycol can increase drug solubility in the stratum corneum so 
the amount of drug that passes through the skin can increase [24-29].
CONCLUSION
Based on the result, it can be found that the activity of eugenol in 
essential oil of clove in absorption base ointment can be increased with 
the addition of enhancer. Its activity was better than natrium diclofenac 
in positive control. The formula containing propylene glycol needs to 
be evaluated for its anti-inflammatory activity for a longer duration to 
ensure its effectivity.
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